Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,682.00    18.00 (1.08%)
Bid:
1,666.00
Ask:
1,688.00
Spread: 22.00 (1.321%)
Market Cap: £495.38m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Director/PDMR Shareholding

29 Nov 2022 14:00

RNS Number : 9679H
Avon Protection PLC
29 November 2022
 

29 November 2022

Avon Protection plc ("the Company")

PDMRs' Interest in Shares

Release of 2020 deferred bonus shares

As previously announced to shareholders on 8 December 2020, a portion of the annual bonus payments due to PDMRs Miles Ingrey-Counter and James Wilcox in respect of the 2020 financial year were deferred into Company shares, to be held for two years.

On 25 November 2022, following expiry of the deferral period, 359 deferred bonus shares were released to Miles Ingrey-Counter and 456 to James Wilcox.

1

Details of person discharging managerial responsibilities/person closely associated

a)

Name

1) Miles Ingrey-Counter

2) James Wilcox

2

Reason for the notification

a)

Position / status

1) Company Secretary

2) Chief Technical Officer

b)

Initial notification /

amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Avon Protection plc

b)

LEI

213800JM1AN62REBWA71

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the

financial instrument

and ISIN Code

Ordinary £1 shares in Avon Protection plc

 

GB0000667013

b)

Nature of the

transaction

Shares released under the 2020 deferred bonus scheme. The shares were purchased on 7 December 2020 for £40.04 and were released following expiry of the 2020 deferral period on 22 November 2022.

c)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

1) Nil

2) Nil

 

1) 359

2) 456

 

d)

Aggregated Information

Aggregated volume

Aggregated price

Aggregated total

 

 

 

815

Nil

Nil

e)

Date of the

transactions

All occurred on 25 November 2022.

 

f)

Place of the

transaction

Outside of a trading venue.

 

 

 

 2022 deferred bonus arrangements

 

A portion of the annual bonus payments due to the Executive Director Rich Cashin and certain PDMRs of the Company in respect of the 2022 financial year were deferred into Company shares on the 25 November 2022. 25% of the annual bonus for the Executive Director, and 25% of the annual bonus linked to financial targets (as distinct from personal performance targets) for the PDMRs, was subject to tax and national insurance/social security and the net amount was used to purchase Company shares. The shares are to be held for two years and are not subject to the Company's shareholding guidelines.

 

The table below sets out the number of 2022 deferred bonus shares held by the Executive Director and each PDMR following this transaction.

 

1

Details of person discharging managerial responsibilities/person closely associated

a)

Name

1) Rich Cashin

2) Miles Ingrey-Counter

3) James Wilcox

4) Steve Genzer

2

Reason for the notification

a)

Position / status

1) Chief Financial Officer

2) Company Secretary

3) Chief Technical Officer

4) Chief Operating Officer

b)

Initial notification /

amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Avon Protection plc

b)

LEI

213800JM1AN62REBWA71

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the

financial instrument

and ISIN Code

Ordinary £1 shares in Avon Protection plc

 

GB0000667013

b)

Nature of the

transaction

Acquisition of shares. 25% of the annual bonus payments for Executive Directors and 25% of the annual bonus payments linked to financial targets (as distinct from personal performance targets) for the PDMRs, was subjected to tax and national insurance/social security and the net amount was used to purchase Company shares. The shares are to be held for two years and are not subject to the Company's shareholding guidelines.

c)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

1) 11.73

2) 11.73

3) 11.73

4) 11.73

1) 1,185

2) 800

3) 849

4) 1,321

 

d)

- Aggregated volume

- Aggregated price

- Aggregated total

 

 

N/A

e)

Date of the

transactions

All occurred on 2022-11-25

 

f)

Place of the

transaction

London Stock Exchange (XLON)

 

 

LEI: 213800JM1AN62REBWA71Classification: Transactions by PDMRs under article 19 of the Market Abuse Regulation.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHXKLFLLFLEFBZ
Date   Source Headline
20th Dec 201712:16 pmRNSHolding(s) in Company
18th Dec 201710:18 amRNSNotice of Annual Report and Accounts and AGM
6th Dec 20173:39 pmRNSDirector/PDMR Shareholding
6th Dec 20172:14 pmRNSDirector/PDMR Shareholding
6th Dec 20177:00 amRNSUS Department of Defense Mask Systems Order
30th Nov 20174:20 pmRNSDirector/PDMR Shareholding
29th Nov 201711:10 amRNSDirector/PDMR Shareholding
24th Nov 20174:39 pmRNSDirector/PDMR Shareholding
15th Nov 20177:00 amRNSFinal Results
8th Nov 20177:00 amRNSAward of US JE-RDAP CBRNe framework contract
7th Nov 201712:15 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:30 pmRNSPreferred bidder nomination
6th Oct 20173:42 pmRNSDirector/PDMR Shareholding
20th Sep 20175:01 pmRNSHolding(s) in Company
15th Sep 20177:00 amRNSPre-close trading update
12th Sep 20179:13 amRNSDirector/PDMR Shareholding
8th Sep 20179:07 amRNSDirector/PDMR Shareholding
4th Sep 201711:06 amRNSHolding(s) in Company
31st Aug 20174:08 pmRNSDirector/PDMR Shareholding
21st Aug 20172:06 pmRNSHolding(s) in Company
21st Aug 20171:53 pmRNSHolding(s) in Company
17th Aug 20177:00 amRNSAppointment of Corporate Broker
14th Aug 20179:59 amRNSDirector/PDMR Shareholding
9th Aug 201710:16 amRNSDirector/PDMR Shareholding
8th Aug 20173:33 pmRNSDirector/PDMR Shareholding
8th Aug 20171:23 pmRNSHolding(s) in Company
31st Jul 201711:03 amRNSDirector/PDMR Shareholding
6th Jul 20171:18 pmRNSDirectors'/PDMR Shareholdings - SIP
6th Jun 201711:51 amRNSDirector/PDMR Shareholding
23rd May 20177:00 amRNSContract Award
16th May 20177:00 amRNSHalf-year Report
10th May 20177:00 amRNSDirectorate Change
8th May 201712:31 pmRNSDirector/PDMR Shareholding
6th Apr 20174:03 pmRNSDirector/PDMR Shareholding
7th Mar 201710:34 amRNSDirector/PDMR Shareholding
17th Feb 20175:45 pmRNSHolding(s) in Company
15th Feb 20172:34 pmRNSDirector/PDMR Shareholding
15th Feb 20177:00 amRNSDirectorate Change
8th Feb 20174:11 pmRNSDirector/PDMR Shareholding
3rd Feb 20175:22 pmRNSHolding(s) in Company
2nd Feb 20175:13 pmRNSResult of AGM
2nd Feb 20177:00 amRNSTrading Update
26th Jan 20179:37 amRNSHolding(s) in Company
9th Jan 201710:20 amRNSDirector/PDMR Shareholding
3rd Jan 201710:14 amRNSHolding(s) in Company
20th Dec 20168:52 amRNSHolding(s) in Company
9th Dec 201610:43 amRNSDirector/PDMR Shareholding
9th Dec 201610:42 amRNSAnnual Report and Financial Statements 2015
7th Dec 20164:07 pmRNSDirector/PDMR Shareholding
5th Dec 20163:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.